submitter_follow_up_id,program_id,submitter_donor_id,submitter_primary_diagnosis_id,submitter_treatment_id,date_of_followup,disease_status_at_followup,relapse_type,date_of_relapse,method_of_progression_status,anatomic_site_progression_or_recurrence
FOLLOW_UP_0001,SYNTH_01,DONOR_0001,DIAG_0001,,"{'day_interval': 1524, 'month_interval': 50}",Relapse or recurrence,Distant recurrence/metastasis,,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0002,SYNTH_01,DONOR_0002,,TREATMENT_0003,"{'day_interval': 1077, 'month_interval': 35}",Stable,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0003,SYNTH_01,DONOR_0003,,,,,Progression (liquid tumours),,Physical examination procedure (procedure)|Imaging (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0004,SYNTH_01,DONOR_0004,DIAG_0004,,"{'day_interval': 3943, 'month_interval': 129}",,Local recurrence,,Histopathology test (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0005,SYNTH_01,DONOR_0005,,TREATMENT_0009,,Stable,Progression (liquid tumours),,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0006,SYNTH_01,DONOR_0006,,,"{'day_interval': 3853, 'month_interval': 126}",,Progression (liquid tumours),,Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0007,SYNTH_01,DONOR_0007,DIAG_0007,,"{'day_interval': 1687, 'month_interval': 55}",No evidence of disease,Local recurrence,,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0008,SYNTH_01,DONOR_0008,,TREATMENT_0015,"{'day_interval': 1003, 'month_interval': 32}",,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0009,SYNTH_01,DONOR_0009,,,"{'day_interval': 1867, 'month_interval': 61}",No evidence of disease,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0010,SYNTH_01,DONOR_0010,DIAG_0010,,"{'day_interval': 7557, 'month_interval': 248}",Distant progression,Distant recurrence/metastasis,"{'day_interval': 1097, 'month_interval': 36}",Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0011,SYNTH_02,DONOR_0021,,TREATMENT_0041,"{'day_interval': 785, 'month_interval': 25}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 471, 'month_interval': 15}",Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0012,SYNTH_02,DONOR_0022,,,"{'day_interval': 2232, 'month_interval': 73}",,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0013,SYNTH_02,DONOR_0023,DIAG_0023,,"{'day_interval': 3309, 'month_interval': 108}",Distant progression,Local recurrence,,Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0014,SYNTH_02,DONOR_0024,,TREATMENT_0047,"{'day_interval': 483, 'month_interval': 15}",Stable,Local recurrence,,Histopathology test (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0015,SYNTH_02,DONOR_0025,,,"{'day_interval': 2206, 'month_interval': 72}",Stable,Distant recurrence/metastasis,,Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0016,SYNTH_02,DONOR_0026,DIAG_0026,,"{'day_interval': 3828, 'month_interval': 125}",Complete remission,Progression (liquid tumours),,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0017,SYNTH_02,DONOR_0027,,TREATMENT_0053,,Partial remission,Progression (liquid tumours),,Imaging (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0018,SYNTH_02,DONOR_0028,,,"{'day_interval': 1858, 'month_interval': 61}",Stable,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0019,SYNTH_02,DONOR_0029,DIAG_0029,,"{'day_interval': 7190, 'month_interval': 236}",Distant progression,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0020,SYNTH_02,DONOR_0030,,TREATMENT_0059,"{'day_interval': 486, 'month_interval': 15}",No evidence of disease,Local recurrence,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0021,SYNTH_03,DONOR_0041,,,,Partial remission,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0022,SYNTH_03,DONOR_0042,DIAG_0042,,"{'day_interval': 2057, 'month_interval': 67}",No evidence of disease,Progression (liquid tumours),,Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0023,SYNTH_03,DONOR_0043,,TREATMENT_0085,,Distant progression,Progression (liquid tumours),"{'day_interval': 215, 'month_interval': 7}",Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0024,SYNTH_03,DONOR_0044,,,"{'day_interval': 1993, 'month_interval': 65}",Stable,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Imaging (procedure),
FOLLOW_UP_0025,SYNTH_03,DONOR_0045,DIAG_0045,,,Relapse or recurrence,Progression (liquid tumours),,Imaging (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0026,SYNTH_03,DONOR_0046,,TREATMENT_0091,,Loco-regional progression,Progression (liquid tumours),"{'day_interval': 329, 'month_interval': 10}",Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0027,SYNTH_03,DONOR_0047,,,,Loco-regional progression,Biochemical progression,"{'day_interval': 162, 'month_interval': 5}",Assessment of symptom control (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0028,SYNTH_03,DONOR_0048,DIAG_0048,,,,Local recurrence,,Imaging (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0029,SYNTH_03,DONOR_0049,,TREATMENT_0097,,Complete remission,Local recurrence and distant metastasis,,Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0030,SYNTH_03,DONOR_0050,,,"{'day_interval': 2243, 'month_interval': 73}",Distant progression,Biochemical progression,"{'day_interval': 2226, 'month_interval': 73}",Assessment of symptom control (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0031,SYNTH_04,DONOR_0061,DIAG_0061,,"{'day_interval': 2965, 'month_interval': 97}",Stable,Biochemical progression,,Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0032,SYNTH_04,DONOR_0062,,TREATMENT_0123,,,Biochemical progression,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0033,SYNTH_04,DONOR_0063,,,"{'day_interval': 3480, 'month_interval': 114}",Complete remission,Biochemical progression,,Imaging (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0034,SYNTH_04,DONOR_0064,DIAG_0064,,"{'day_interval': 4082, 'month_interval': 134}",Relapse or recurrence,Biochemical progression,,Imaging (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0035,SYNTH_04,DONOR_0065,,TREATMENT_0129,"{'day_interval': 881, 'month_interval': 28}",Complete remission,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0036,SYNTH_04,DONOR_0066,,,"{'day_interval': 1521, 'month_interval': 49}",Relapse or recurrence,Biochemical progression,,Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0037,SYNTH_04,DONOR_0067,DIAG_0067,,"{'day_interval': 1194, 'month_interval': 39}",,Progression (liquid tumours),,Tumor marker measurement (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0038,SYNTH_04,DONOR_0068,,TREATMENT_0135,"{'day_interval': 623, 'month_interval': 20}",Stable,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0039,SYNTH_04,DONOR_0069,,,"{'day_interval': 14759, 'month_interval': 484}",Complete remission,Local recurrence and distant metastasis,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0040,SYNTH_04,DONOR_0070,DIAG_0070,,"{'day_interval': 762, 'month_interval': 25}",Loco-regional progression,Progression (liquid tumours),"{'day_interval': 85, 'month_interval': 2}",Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_NULL_0001,SYNTH_01,DONOR_NULL_0001,,TREATMENT_NULL_0001,,,,,,
FOLLOW_UP_NULL_0002,SYNTH_01,DONOR_NULL_0002,,,"{'day_interval': 1832, 'month_interval': 60}",,,,,
FOLLOW_UP_ALL_0001,SYNTH_01,DONOR_ALL_0001,DIAG_ALL_0001,,,Relapse or recurrence,Distant recurrence/metastasis,,Imaging (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_ALL_0002,SYNTH_01,DONOR_ALL_0002,,TREATMENT_ALL_0003,"{'day_interval': 857, 'month_interval': 28}",,Progression (liquid tumours),,Histopathology test (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
